Search for: "Nelson v. USA" Results 141 - 160 of 171
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Aug 2012, 5:00 am by Bexis
Bernhardt (cervical interbody fusion system) Deposition2001-02-12 Nelson v. [read post]
2 Mar 2012, 6:52 am by Bexis
Bernhardt (cervical interbody fusion system) Deposition2001-02-12 Nelson v. [read post]
4 Nov 2018, 10:56 am by Schachtman
(USA) LLC, 752 F.3d 82, 85 (1st Cir. 2014) (affirming exclusion of expert witness whose event study and causal conclusion failed to consider relevant [read post]
30 Dec 2018, 3:03 am by Ben
Court of Appeals, Ninth Circuit in Folkens v Wyland. [read post]
11 Apr 2017, 3:01 pm
(Pix © Larry Catá Backer 2016) I will be teaching a course on Corporate Social Responsibility. [read post]
18 Jun 2020, 11:40 pm by Schachtman
Mom was the Grand Dame of the know-nothing Republican party after she helped kill off the Nelson Rockefeller wing of the G.O.P. [read post]
25 Oct 2008, 12:18 am
Swisa: implications for India (Spicy IP) Centre for Science and Environment accused of copyright infringement by Mint's editor (Spicy IP) Delhi High Court dicta on fair dealing increases woes of news channels: ESPN Stars Sports v. [read post]
23 Dec 2023, 7:16 pm by admin
“Know then thyself, presume not God to scan; The proper study of Mankind is Man. [read post]
12 Jul 2012, 9:32 pm
Nashville: Thomas Nelson Publishers.] [read post]
26 Oct 2016, 1:41 pm by Steve Lubet
Mallow, Deborah Dash Moore, Sharon Ann Musher, Cary Nelson, Kenneth S. [read post]
24 Sep 2023, 9:01 pm by renholding
  As we discuss further in Section IV, SB 264 is also the subject of  a constitutional and statutory challenge in the federal courts in the case of Shen v. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
15 Mar 2010, 2:09 pm by Robinson, Calcagnie & Robinson
BIC USA, Inc., 136 F.Supp.2d 196, 207-208 (S.D.N.Y. 2000) (Consumer Product Safety Commission) (“The CPSC regulations establish general, rudimentary and minimal requirements. [read post]
2 May 2011, 8:12 am by Kara OBrien
The following is our monthly featured post from Terry Nelson & Peter Fetzer of Foley & Lardner filling you in on the latest SEC developments. [read post]